In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.10.2444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Novel Triterpene Sulfates From Fusarium Compactum Using a Rhinovirus 3C Protease Inhibitor Screen.

Journal of Antibiotics
Drug DiscoveryPharmacology
1996English

Synthesis, Crystal Structure, Structure-Activity Relationships, and Antiviral Activity of a Potent SARS Coronavirus 3CL Protease Inhibitor

English

Human Rhinovirus 3C Protease Cleaves RIPK1, Concurrent With Caspase 8 Activation

Scientific Reports
Multidisciplinary
2018English

Activity of the Human Rhinovirus 3C Protease Studied in Various Buffers, Additives and Detergents Solutions for Recombinant Protein Production

PLoS ONE
Multidisciplinary
2016English

Citrinin Hydrate and Radicinin: Human Rhinovirus 3c-Protease Inhibitors Discovered in a Target-Directed Microbial Screen.

Journal of Antibiotics
Drug DiscoveryPharmacology
1994English

Potent Antimycobacterial Activity of Mouse Secretory Leukocyte Protease Inhibitor

Journal of Immunology
AllergyImmunology
2008English

In Vitro Antiviral Profile of Ruzasvir: A Potent and Pan-Genotype Inhibitor of HCV NS5A

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Rhinovirus 3C Protease Suppresses Apoptosis and Triggers Caspase-Independent Cell Death

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy